| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| INVO FERTILITY Aktie jetzt für 0€ handeln | |||||
| 28.08. | INVO Fertility, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 5 | SEC Filings | ||
| 28.08. | INVO Fertility, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 17.08. | INVO Fertility: Clinic-Level EBITDA More Than Doubles Sequentially | 3 | pulse2.com | ||
| 17.08. | INVO BioScience GAAP EPS of $0.35 beats by $5.55, revenue of $2.18M misses by $0.53M | 18 | Seeking Alpha | ||
| 17.08. | INVO Fertility, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 14.08. | INVO Fertility, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 24.07. | INVO Fertility, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 24.07. | INVO Fertility, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.06. | INVO Fertility, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.06. | INVO Fertility, Inc. Q1 Loss Drops | 2 | RTTNews | ||
| 22.06. | INVO Fertility, Inc.: INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure | 455 | GlobeNewswire (Europe) | 23% revenue growth, elimination of all Series C-2 Preferred Stock and warrant liabilities, and a strengthened balance sheet Growth reflects both organic clinic initiatives and acquisition contribution... ► Artikel lesen | |
| 22.06. | INVO Fertility, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 16.06. | INVO Fertility, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.06. | INVO Fertility, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 02.06. | INVO Fertility receives Nasdaq delisting notice for late filings | 2 | Investing.com | ||
| 02.06. | INVO Fertility receives Nasdaq notice over delayed SEC filings | 2 | Seeking Alpha | ||
| 02.06. | Nasdaq warnt INVO Fertility wegen verspäteter Finanzberichte | 1 | Investing.com Deutsch | ||
| 02.06. | INVO Fertility, Inc.: INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q | 212 | GlobeNewswire (Europe) | SARASOTA, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO" or the "Company"), a healthcare services fertility company, today announced that on May 27, 2026, it received... ► Artikel lesen | |
| 02.06. | INVO BioScience GAAP EPS of -$214.64, revenue of $6.84M | 2 | Seeking Alpha | ||
| 02.06. | Bilanzierungsfehler zwingen INVO Fertility zur Korrektur von Quartalszahlen | 4 | Investing.com Deutsch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 369,90 | -0,20 % | Intuitive Surgical: Bewertungsabschlag ohne Bruch der Investment-Story - Chance für geduldige Qualitätsanleger? | Intuitive Surgical bleibt operativ auf Kurs, während die Bewertung nachgibt. Trotz temporärer Belastungen durch Nachholeffekte aus der Pandemie und makroökonomische Unsicherheiten sieht Seeking Alpha... ► Artikel lesen | |
| UNITEDHEALTH | 329,00 | -0,54 % | UnitedHealth (NYSE:UNH): America's Health System Creates The Opportunity For The Largest Listed Health Care Company! | ||
| THERMO FISHER | 579,80 | -0,24 % | Thermo Fisher Scientific: Strategische Neuausrichtung und Margenwachstum! | ||
| HIMS & HERS HEALTH | 25,360 | +1,36 % | Truist reiterates Hold on Hims and Hers stock, $32 target | ||
| FAMICORD | 2,970 | -2,30 % | EQS-News: FamiCord AG gewinnt vielversprechenden CDMO-Neukunden mit Herstellungsvereinbarung für zulassungsrelevante Phase-II/III-Studie bei anfänglichem Volumen im niedrigen einstelligen Millionen-Euro-Bereich | EQS-News: FamiCord AG
/ Schlagwort(e): Vertrag
FamiCord AG gewinnt vielversprechenden CDMO-Neukunden mit Herstellungsvereinbarung für zulassungsrelevante Phase-II/III-Studie bei... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 125,95 | +0,20 % | Align Technology hit as appeals court revives dental aligners antitrust claims | ||
| HEALWELL AI | 0,460 | -1,60 % | HEALWELL AI: HEALWELL AI Provides Research Update on Peer-Reviewed MyHealthNB Study and Global Recognition of DARWEN | Peer-reviewed research published in the Journal of Medical Internet Research (JMIR) reports that VeroSource's MyHealth patient app was associated with statistically significant, self-reported improvements... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,180 | +0,93 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| TECAN GROUP | 249,00 | +0,89 % | Tecan Group AG: Tecan nimmt an Investorenkonferenz teil | Männedorf, Schweiz, 10. September 2026 - Die Tecan Group (SIX Swiss Exchange: TECN) gab heute bekannt, dass das Unternehmen in der nächsten Woche an folgender Konferenz teilnehmen wird:
24th Annual... ► Artikel lesen | |
| CENTENE | 57,58 | +0,03 % | CENTENE CORP - 8-K, Current Report | ||
| TANDEM DIABETES | 13,500 | -3,57 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| NETRAMARK | 0,408 | -2,39 % | NetraMark Holdings Inc.: NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness | TORONTO, July 13, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence company transforming clinical... ► Artikel lesen | |
| MOLINA HEALTHCARE | 171,90 | -1,55 % | $1000 Invested In Molina Healthcare 15 Years Ago Would Be Worth This Much Today | ||
| QUIDELORTHO | 10,840 | -2,03 % | Sanjeev Sharma wird neuer Leiter Investor Relations bei QuidelOrtho |